FDA tightens monitoring of VAT-exempt medicines, fake drugs

The Food and Drug Administration (FDA) is strengthening its monitoring of value-added tax (VAT) exempt medicines to ensure lower prices for consumers while stepping up enforcement against counterfeit and unregistered drugs.

Original source: GMA News